BNP Paribas Financial Markets
CRGX

BNP Paribas Financial Markets’s CARGO Therapeutics CRGX Stock Holding History

BNP Paribas Financial Markets’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-137,094
Closed -$565K – 5588
2025
Q2 		$565K Buy
137,094
+94,776
+224% +$406K ﹤0.01% 3258
2025
Q1 		$172K Buy
42,318
+38,404
+981% +$257K ﹤0.01% 3782
2024
Q4 		$56.4K Sell
3,914
-7,524
-66% -$137K ﹤0.01% 4387
2024
Q3 		$211K Buy
11,438
+9,311
+438% +$167K ﹤0.01% 3239
2024
Q2 		$34.9K Sell
2,127
-8,537
-80% -$162K ﹤0.01% 3539
2024
Q1 		$238K Buy
+10,664
New +$254K ﹤0.01% 3202

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's CRGX Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 137,094 shares — an estimated $565K sold.

BNP Paribas Financial Markets first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $565K in Q2 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 137,094 CARGO Therapeutics shares in Q3 2025, an estimated $565K.
  • BNP Paribas Financial Markets first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
  • BNP Paribas Financial Markets's CARGO Therapeutics position peaked at $565K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.